![Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01734-18/asset/cc9c06a1-8c39-4d82-be42-32ac89f5c458/assets/graphic/aac.01734-18-f0003.jpeg)
Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
![PDF) Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator Against the Hepatitis B Virus PDF) Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator Against the Hepatitis B Virus](https://www.researchgate.net/profile/Suping-Ren-4/publication/328581895/figure/tbl1/AS:720476343132168@1548786354358/Antiviral-activities-of-NVR-3-778-and-LMV-against-wild-type-HBV-and-HBV-core-protein_Q320.jpg)
PDF) Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator Against the Hepatitis B Virus
![Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01734-18/asset/a60cd1dc-f19a-46b3-8dbc-5c101068030b/assets/graphic/aac.01734-18-f0001.jpeg)
Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
![Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01734-18/asset/019649c6-4a89-404a-b7fa-74406a569dc7/assets/graphic/aac.01734-18-f0004.jpeg)
Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
![Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01734-18/asset/cbb15a80-8c14-48d4-9b35-ef8373ca85a7/assets/graphic/aac.01734-18-f0002.jpeg)
Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
![PDF) Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator Against the Hepatitis B Virus PDF) Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator Against the Hepatitis B Virus](https://i1.rgstatic.net/publication/328581895_Preclinical_Characterization_of_NVR_3-778_a_First-in-Class_Capsid_Assembly_Modulator_Against_the_Hepatitis_B_Virus/links/5d1f7c7b458515c11c151c6b/largepreview.png)